Dr. Robert J. Kaplan, MD
Dermatology (Dermatology Physician)
- Medicare participating
At a glance
- Medical school
- University of Tennessee, Hsc, College of Medicine (1973)
- Years since graduation
- 53
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 943
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1973Medical school: University of Tennessee, Hsc, College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
TN license 8281
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare patients and services
- Medicare patients, 2024
- 943
- Services billed
- 7,849
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Biopsy of related skin growth, each additional growth | 3,221 | 751 |
| Biopsy of related skin growth, first growth | 1,631 | 852 |
| Established patient office or other outpatient visit, 20-29 minutes | 1,372 | 659 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 1,054 | 105 |
| Injection, methylprednisolone acetate, 40 mg | 532 | 104 |
| Injection into skin growth, more than 7 growths | 462 | 188 |
| Established patient office or other outpatient visit, 30-39 minutes | 388 | 281 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 113 | 82 |
| Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | 81 | 54 |
| Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | 77 | 55 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Mupirocin Other prescribers in Memphis, TN | 387 |
| Ketoconazole Other prescribers in Memphis, TN | 241 |
| Betamethasone Valerate Other prescribers in Memphis, TN | 215 |
| Cephalexin Other prescribers in Memphis, TN | 212 |
| Fluocinonide Other prescribers in Memphis, TN | 155 |
| Prednisone Other prescribers in Memphis, TN | 122 |
| Mometasone Furoate Other prescribers in Memphis, TN | 122 |
| Hydrocortisone Other prescribers in Memphis, TN | 100 |
| Triamcinolone Acetonide Other prescribers in Memphis, TN | 87 |
| Alclometasone Dipropionate | 57 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 10 companies reported 32 payments worth $604 in total to this clinician.
| Paratek Pharmaceuticals, Inc. | $156 |
|---|---|
| Pfizer Inc. | $102 |
| Sun Pharmaceutical Industries Inc. | $95.26 |
| Genzyme Corporation | $74.03 |
| Novartis Pharmaceuticals Corporation | $68.62 |
| UCB, Inc. | $37.52 |
| Janssen Biotech, Inc. | $21.24 |
| Organon LLC | $17.26 |
| Food and Beverage | $604 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.